What is Fosfomycin Sodium Market Scope?
Fosfomycin is a phosphoenolpyruvate analog and a synthetic broad-spectrum antibiotic with antimicrobial and bactericidal properties. Fosfomycin binds to the enzyme enol pyruvate transferase and inactivates it. This leads to an irreversible blocking of the condensation of uridine diphosphate-N-acetylglucosamine with p-enol pyruvate, which is one of the first steps in bacterial cell wall synthesis and ultimately leads to cell lysis and bacterial cell death. Fosfomycin is an orally available broad-spectrum antibiotic that is mainly used to treat uncomplicated urinary tract infections. Fosfomycin is associated with jaundice with a low rate of transient serum enzymes during therapy and with rare cases of clinically apparent acute liver damage.
Increasing Healthcare Spending and Demand for Drug Therapy
Market Growth Drivers:
Growing Geriatric Population in Major Economies, Growing Cases of Urinary Tract Infections and Increase in the Unhygienic Conditions of Toilets
Availability of Substitute Drugs in the Market
Stringent Government Rules and Regulation and Side Effects Due to Fosfomycin Sodium
R&D and Product Innovation and Potential Growth From Emerging Countries
The Fosfomycin Sodium market study is being classified by Type (Tablets and Injection), by Application and major geographies with country level break-up.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from Asian will contribute to the maximum growth of Global Fosfomycin Sodium market throughout the predicted period.
Merck Group (Germany), AdvaCare Pharma (United States), LGM Pharma (United States), Cipla (India), Northeast Pharmaceutical Group Co. Ltd. (China), Ercros (Spain), SGPharma Pvt. Ltd. (India), Shin Poong Pharm Co. Ltd. (South Korea), Sundent Pharm Group (China) and Hubei Xunda Pharmaceutical (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are FarmaSino Pharmaceutical (China) and National Analytical Corporation (India).
Analyst at AMA have segmented the market study of Global Fosfomycin Sodium market by Type, Application and Region.
On the basis of geography, the market of Fosfomycin Sodium has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their Development Strategies
In October 2023, Hikma Pharmaceuticals launched Fosmicin IV (fosfomycin trometamol for injection) in the US market, expanding access to this important antibiotic for treating multidrug-resistant (MDR) Gram-negative bacterial infections.
In December 2023, Spero Therapeutics received FDA approval for Orbactiv (omadacycline), a new tetracycline antibiotic indicated for complicated urinary tract infections (cUTI) and acute bacterial skin and skin structure infections (ABSSSI). Omadacycline has a similar mechanism of action to Fosfomycin Sodium,
Key Target AudienceManufacturers of Fosfomycin Sodium, Suppliers and Distributors of Fosfomycin Sodium, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others
Fosfomycin Sodium Market Study: Important Years
|Value (USD Million)
|Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility
Major Highlights of Market Study
Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Fosfomycin Sodium Market.
Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.
Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Fosfomycin Sodium industry is examined with reference relevant market sectors and sub-sectors.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.